OppenheimerFunds’s Neenah, Inc. Common Stock NP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$557K Buy
8,651
+613
+8% +$40.7K ﹤0.01% 1322
2018
Q4
$474K Buy
8,038
+990
+14% +$71.7K ﹤0.01% 1396
2018
Q3
$608K Sell
7,048
-456
-6% -$40.7K ﹤0.01% 1354
2018
Q2
$637K Sell
7,504
-18
-0.2% -$1.46K ﹤0.01% 1320
2018
Q1
$590K Sell
7,522
-230
-3% -$19.5K ﹤0.01% 1332
2017
Q4
$703K Sell
7,752
-549
-7% -$48.1K ﹤0.01% 1345
2017
Q3
$710K Sell
8,301
-751
-8% -$59.5K ﹤0.01% 1343
2017
Q2
$727K Sell
9,052
-556
-6% -$43.2K ﹤0.01% 1318
2017
Q1
$718K Buy
9,608
+2,748
+40% +$217K ﹤0.01% 1326
2016
Q4
$584K Buy
6,860
+1,101
+19% +$91.2K ﹤0.01% 1306
2016
Q3
$455K Sell
5,759
-305
-5% -$23.4K ﹤0.01% 1304
2016
Q2
$439K Sell
6,064
-893
-13% -$60.1K ﹤0.01% 1295
2016
Q1
$443K Sell
6,957
-120
-2% -$7.14K ﹤0.01% 1273
2015
Q4
$442K Buy
+7,077
New +$456K ﹤0.01% 1333

Other funds holding NP

OppenheimerFunds's NP Position: Q1 2019 in Review

OppenheimerFunds increased its Neenah, Inc. Common Stock (NP) stake by 7.6% in Q1 2019, buying an estimated $40.7K and bringing the position to 8,651 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

OppenheimerFunds first reported a position in NP in Q4 2015 and has held it in 14 quarters since. The position peaked at $727K in Q2 2017. 196 funds tracked by Wall St. Rank hold NP as of Q1 2019.

  • OppenheimerFunds held 8,651 shares of Neenah, Inc. Common Stock worth $557K as of Q1 2019.
  • OppenheimerFunds bought 613 Neenah, Inc. Common Stock shares in Q1 2019, an estimated $40.7K.
  • Neenah, Inc. Common Stock made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1322 holding.
  • OppenheimerFunds first reported a position in Neenah, Inc. Common Stock in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Neenah, Inc. Common Stock position peaked at $727K in Q2 2017.
  • 196 funds tracked by Wall St. Rank held Neenah, Inc. Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.